AI THERAPEUTICS Trademark

Trademark Overview


On Friday, December 21, 2018, a trademark application was filed for AI THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AI THERAPEUTICS trademark a serial number of 88238864. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by AI Therapeutics, Inc.. The AI THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases

Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases
ai therapeutics

General Information


Serial Number88238864
Word MarkAI THERAPEUTICS
Filing DateFriday, December 21, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements


Description of MarkThe mark consists of a design of a central point with three immediate extending lines. The top and left lines branch into two similar lines with rounded circular ends and the right line contains an additional line on one side and a single dot on the other side. To the right of the design are the words "AI THERAPEUTICS".
Goods and ServicesPharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases
Pseudo MarkARTIFICIAL INTELLIGENCE THERAPEUTICS
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS" IN CLASS 005 AND "AI THERAPEUTICS" IN CLASS 042
Goods and ServicesPharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAI Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGuilford, CT 06437

Party NameAI Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGuilford, CT 06437

Trademark Events


Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 12, 2022SOU EXTENSION 5 GRANTED
Thursday, August 4, 2022SOU EXTENSION 5 FILED
Friday, August 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 4, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022SOU EXTENSION 4 GRANTED
Tuesday, February 8, 2022SOU EXTENSION 4 FILED
Tuesday, February 8, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 9, 2021SOU EXTENSION 3 GRANTED
Monday, August 9, 2021SOU EXTENSION 3 FILED
Monday, August 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 5, 2021SOU EXTENSION 2 GRANTED
Friday, February 5, 2021SOU EXTENSION 2 FILED
Friday, February 5, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020SOU EXTENSION 1 GRANTED
Monday, August 10, 2020SOU EXTENSION 1 FILED
Monday, August 10, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 13, 2019ASSIGNED TO LIE
Thursday, November 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 6, 2019NON-FINAL ACTION E-MAILED
Sunday, October 6, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 19, 2019NON-FINAL ACTION E-MAILED
Tuesday, March 19, 2019NON-FINAL ACTION WRITTEN
Sunday, March 17, 2019ASSIGNED TO EXAMINER
Wednesday, January 16, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED